NCT06402175View on ClinicalTrials.gov

Characteristics and Outcomes of Patients With Hematological Malignancies

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

April 1, 2027

Conditions
Haematologic Neoplasm
Interventions
OTHER

follow up

follow up

All Listed Sponsors
lead

Assiut University

OTHER

NCT06402175 - Characteristics and Outcomes of Patients With Hematological Malignancies | Biotech Hunter | Biotech Hunter